Business Context and Reporting Period
Company: Provident Companies, Inc. (Note: The filing metadata references "Unum Group," but the document text identifies the registrant as Provident Companies, Inc., which later became Unum Group).
Date: March 27, 1997
Event: Completion of the acquisition of The Paul Revere Corporation ("Paul Revere") via a merger with a wholly-owned subsidiary, Patriot Acquisition Corporation.
Key Financial Metrics and Transaction Details
- Merger Consideration: Paul Revere shareholders could elect:
- $26.00 in cash per share.
- 0.767 shares of Provident Common Stock per share.
- $20.00 cash plus 0.177 shares of Provident Common Stock per share.
- Textron Consideration: Shares held by Textron Inc. were converted to $20.00 cash plus 0.1578 shares of Provident Common Stock per share.
- Funding Sources: Cash payments funded by proceeds from a stock sale to Zurich Insurance Company and borrowings under an existing $800 million revolving credit facility.
- Zurich Transaction: Provident sold 9,523,810 shares of its common stock to Zurich Insurance Company for $300.0 million in cash.
- Textron Contributions: Textron contributed $121.0 million in cash and approximately $15 million in other assets to Paul Revere, and paid an additional $25 million in cash to Provident.
Material Changes
The primary material change is the consolidation of Paul Revere into Provident, significantly altering the company's asset base and shareholder structure. The transaction resulted in:
- Issuance of new Provident Common Stock to Paul Revere shareholders and Textron.
- Receipt of $300.0 million in cash from Zurich Insurance Company.
- Receipt of $121.0 million in cash and $15 million in assets from Textron.
- Assumption of debt obligations to fund the cash portion of the merger consideration.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the successful consummation of the merger and the related financing arrangements. It details the specific agreements governing the relationship with Textron and Zurich, including voting restrictions and registration rights.
Risks and Contingencies:
- Financing Risk: Reliance on the $800 million credit facility and the Zurich stock sale to fund cash obligations.
- Shareholder Restrictions: Textron is subject to a Standstill Agreement restricting voting and disposition of Provident shares. Zurich is subject to acquisition restrictions but may nominate up to two directors.
- Integration: The filing references pro forma financial information (Exhibit 99.2) but does not provide specific integration risks or synergies in the text provided.
Investor Verification Checklist
- Verify the exact number of shares issued to Paul Revere shareholders and Textron to calculate total dilution.
- Review the Pro Forma Financial Information (Exhibit 99.2) to assess the combined entity's leverage and earnings impact.
- Confirm the terms of the $800 million credit facility and the amount drawn to fund the merger.
- Examine the audited financial statements of Paul Revere (Exhibit 99.1) for pre-merger financial health.
- Review the specific voting and standstill restrictions placed on Textron and Zurich to understand future governance dynamics.